CN Patent

CN101072755A — Hedgehog信号转导的吡啶基抑制剂

Assigned to Genentech Inc · Expires 2007-11-14 · 19y expired

What this patent protects

本发明提供用作治疗剂用于治疗恶性肿瘤的hedgehog信号转导的新的抑制剂，其中所述化合物具有通式I的结构，其中A、X、Y、R 1 、R 2 、R 3 、R 4 和n如本文所述。

USPTO Abstract

本发明提供用作治疗剂用于治疗恶性肿瘤的hedgehog信号转导的新的抑制剂，其中所述化合物具有通式I的结构，其中A、X、Y、R 1 、R 2 、R 3 、R 4 和n如本文所述。

Drugs covered by this patent

Patent Metadata

Patent number
CN101072755A
Jurisdiction
CN
Classification
—
Expires
2007-11-14
Drug substance claim
No
Drug product claim
No
Assignee
Genentech Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.